







Atlas Genet Cytogenet Oncol Haematol. 2013; 17(7)  487 
INIST-CNRS 
 
OPEN ACCESS JOURNAL 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
SIAH1 (siah E3 ubiquitin protein ligase 1) 
Yoshito Nagano, Shu-Ichi Matsuzawa 
Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734-8551, Japan 
(YN), Sanford-Burnham Medical Research Institute, La Jolla, CA, 92037, USA (SIM) 
 
Published in Atlas Database: February 2013 
Online updated version : http://AtlasGeneticsOncology.org/Genes/SIAH1ID457ch16q12.html 
DOI: 10.4267/2042/51047 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2013 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Identity 
Other names: SIAH1A 




The human Siah1 gene is composed of 2 exons, 
separated by an intron of roughly 14,5 kb. 
 
Map of chromosome 16 with region 16q12.1 highlighted as the location of the gene SIAH1. 
 
Genomic structure and exon-intron boundaries for SIAH1. The relevant DNA sequences at exon-intron boundaries are indicated, and 
respective amino acid sequences are indicated below in single-letter code. The entire open reading frame of SIAH1 is in exon 2, and its 
initiating methionine is underlined. 
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Schema of Siah1 structure. Siah1 has RING domain at the N-terminus and the substrate binding domain (SBD) at the C-terminus. 
Some substrate proteins are recognized by this substrate binding domain directly, and receive ubiquitin-conjugation. 
 
Pseudogene 
One pseudogene has been reported. 
Protein 
Expression 
Siah1 mRNA is widely expressed in the human tissues. 
It is expressed at higher level in placenta, skeletal 
muscle and testis. 
Localisation 
Siah1 protein can be localized in both cytoplasm and
nucleus. 
Function 
Siah1 is the mammalian homolog of Drosophia seven 
in absentia (SINA) protein (Carthew and Rubin, 1990). 
Siah1 protein plays a key role in biological processes 
such as the cell cycle, programmed cell death, and 
oncogenesis (Nemani et al., 1996). The Siah family of 
RING-domain proteins are components of ubiquitin 
ligase complexes, targeting proteins for proteasomal 
degradation. Numerous substrates targeted for 
degradation by Siah proteins have been reported; 
Synphilin-1 (Nagano et al., 2003), DCC (Hu et al., 
1997), N-CoR (Zhang et al., 1998), BOB1/OBF1 
(Boehm et al., 2001, Tiedt et al., 2001), c-Myb 
(Tanikawa et al., 2000), Kid (Germani et al., 2000) and 
CtIP (Germani et al., 2003). Siah1 expression is 
upregulated by p53, revealing a link between genotoxic 
injury and destruction of β-catenin and reduced T-cell 
factor/lymphoid enhancer factor (Tcf/Lef) activity (Liu 
et al., 2001; Jansen et al., 2009). Recent paper showed 
Siah1 expression facilitates ubiquitination and 
degradation of the tumor suppressor HIPK2 that is a
key regulator of the apoptotic programme induced by 
DNA damage (Winter et al., 2008). 
It has been shown that the nuclear translocation and 
accumulation of GAPDH play important roles in early 
events leading to cell death initiation and execution 
(Sirover, 1999), resulting in the various degenerative 
diseases. Siah1 functions as a potential carrier/shuttle 
proteins for the induction of GAPDH nuclear 
translocation because of its nuclear location signal 
(NLS) domain in Siah1 (Hara et al., 2005). 
Siah1a knockout mice are growth-retarded, exhibit 
early lethality, and display spermatogenetic defects. 
They also exhibit high numbers of osteoclasts with low 
numbers of osteoblasts, resulting in severe osteopenia 
(Frew et al., 2004). 
Homology 
Human: Siah2. 
Mouse: Siah1a, Siah1b, Siah2. 
Mutations 
Note 
There is limited evidence for mutation, with only one 
report of a low frequency of inactivating mutations i  




Wen et al. showed that Siah1 overexpression induced 
cell apoptosis by up-regulating the level of Bim 
through the activation of the JNK signaling pathway, 
and the suppression of Siah1 expression increased cell 
invasion via the activation of the ERK signaling 
pathway in breast cancer cells (Wen et al., 2010a; Wen 
et al., 2010b). 
He et al. showed that overexpression of Siah1 enhanced 
radiation-induced apoptosis in breast cancer cells (He 
et al., 2010).  
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Those data suggest that Siah1 can be a novel 
therapeutic target for tumor cell death. 
Leukemia 
Note 
Krämer et al. showed that the leukemia fusion protein 
PML-RARα (promyelocytic leukemia-retinoic acid 
receptor α which causes acute promyelocytic 
leukemias, is degraded by ubiquitin-proteasome system 
and that their turnover critically depends on the E2-
conjugase UbcH8 and Siah1. They also showed that 
HDAC inhibitor enhanced the degradation of leukemia 
fusion proteins via UbcH8-Siah1 axis and could be a 




Kim et al. found two missense mutations in the SIAH1 
gene in gastric cancer. The two mutants revealed that 
impairment of β-catenin degradation pathway, increase 
of cyclin D1 expression, and inhibition of apoptosis in 
culture cells, suggesting that mutations of Siah1 gene 
may play an important role in the development and 
progression in a subset of gastric cancer through β-




Matsuo et al. showed that the expression level of 
SIAH1 was markedly downregulated in hepatocellular 
carcinoma (HCC), especially in advanced stages 
(Matsuo et al., 2003). Okabe et al. showed that the 
paternally expressed gene 10 (PEG10) was an 
important factor in HCC progression as a substrate for 
Siah1 and could be a novel molecular target for 
treatment (Okabe et al., 2003). 
Parkinson's disease 
Note 
Nagano et al. showed for the first time that Siah1 
ubiquitinated α-synuclein-interacting protein, 
Synphilin-1, leading to degradation. These proteins are 
located in Lewy body, the pathological hallmark of 
Parkinson's disease (Nagano et al., 2003). Recent 
papers showed that Siah1 facilitated mono- or di-
ubiquitination of α-synuclein, leading to Lewy body 
formation (Lee et al., 2008; Rott et al., 2008). But no 
mutation in Siah1 has been identified in Parkinson's 
disease patients (Franck et al., 2006). 
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